A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Authors :: Abboud, Ramzi
Gao, Feng
Rettig, Michael P.
Eisele, Jeremy
Gehrs, Leah
Wallace, Nichols
Abboud, Camille
Westervelt, Peter
Uy, Geoffrey L.
Cashen, Amanda F.
Christopher, Matt
Ghobadi, Armin
Jacoby, Meagan A.
Pusic, Iskra
Stockerl-Goldstein, Keith E.
DiPersio, John F.
Schroeder, Mark A.
Source :: Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p100-100, 1p
Publication Year :: 2021
Abstract: Introduction:

Full Text Access

Tools